dict.md logo
Results for C in English, page 390
Clinical pharmacology section:-:-:^FDA package insert:Nar
Clinical pharmacology section:-:-:^FDA package insert:Narrative
Clinical pharmacology service
Clinical Pharmacy Automation Systems
Clinical Pharmacy Cabinets
Clinical Pharmacy Computer Systems
Clinical Pharmacy Data Management Systems
Clinical Pharmacy Information Systems
Clinical Pharmacy Information Systems, Data Management
Clinical Pharmacy Service
Clinical Pharmacy Services
Clinical physiology department
Clinical physiology service
Clinical Practice Guideline
Clinical Practice Guidelines
Clinical Practice Nursing Research
Clinical Practice Pattern
Clinical Practice Patterns
Clinical Practice Variation
Clinical Practice Variations
Clinical Precision Scales
Clinical presentation
Clinical presentation | patient
Clinical presentation | patient | Bld-Ser-Plas
Clinical presentation Doc
Clinical presentation Document
Clinical presentation varies
Clinical presentation varies from asymptomatic to fulminant course
Clinical presentation:Find:Pt:^Patient:Doc
Clinical presentation:Finding:Point in time:^Patient:Document
Clinical Preventive Practices
Clinical Problem Statements
clinical product invoice
clinical product invoice - ActCode
Clinical Protocol
Clinical Protocol Date Closed Standard Cancer Center Information Summary
Clinical Protocol Date Opened Standard Cancer Center Information Summary
Clinical Protocols
Clinical psychiatric mental status determination
clinical psychiatry (field)
CLINICAL PSYCHOLOGIST
Clinical Psychologist - NUCCProviderCodes
Clinical psychologists
clinical psychology
clinical psychology (field)
Clinical Psychology Graduate Training
Clinical Recorders and Monitors
Clinical records items
Clinical records items | patient
Clinical records items | patient | Bld-Ser-Plas
Clinical records items:-:Point in time:^Patient:-
CLINICAL REFERRAL
clinical referral - EncounterReferralSource
Clinical regeneration
clinical report
Clinical report attachment
Clinical report documentation
Clinical report documentation set
Clinical Report Panels
Clinical reports.non lab claims attachment
Clinical reports.non lab claims attachment | patient
Clinical reports.non lab claims attachment | patient | Bld-Ser-Plas
Clinical reports.non lab claims attachment:Cmplx:-:^Patient:Set
Clinical reports.non lab claims attachment:Complex:-:^Patient:Set
Clinical Research
Clinical Research Associate
CLINICAL RESEARCH COORDINATOR
Clinical Research Curriculum Award (CRCA)
clinical research investigator
Clinical Research Nursing
Clinical Research Protocol
Clinical Research Protocols
clinical research sponsor
Clinical Research Support Shared Resource
Clinical Research, Nursing
Clinical Resource Contractor
Clinical root of tooth
CLINICAL SAMPLE CONCENTRATOR
Clinical Scales
Clinical Sciences
Clinical Sensitivity
Clinical Service
clinical service and product
clinical service and product - ActCode
clinical service invoice
clinical service invoice - ActCode
Clinical Services
Clinical severity varies
Clinical Skill
Clinical Skills
clinical social work
clinical social work child protective services (treatment)
CLINICAL SOCIAL WORKER
Clinical Social Worker - NUCCProviderCodes
Clinical Social Workers
Clinical Specialist in Community Health Nursing
Clinical Specialist in Diabetes Management
Clinical Specialist in Gerontological Nursing
Clinical Specialist in Home Health Nursing
Clinical Specialist in Medical-Surgical Nursing
Clinical Specialist in Oncology Nursing
Clinical Specialist in Pediatric Nursing
Clinical Specialist in Wound, Ostomy, and Continence
Clinical spectrum in males ranges from lethal neonatal onset to milder forms with first recognized episode in late childhood or even in adulthood
CLINICAL STAGE PRIOR TO SURGERY FOR LUNG CANCER AND ESOPHAGEAL CANCER RESECTION WAS RECORDED
Clinical Studies
Clinical studies section
Clinical studies section | FDA package insert
Clinical studies section | FDA package insert | Bld-Ser-Plas
Clinical studies section:-:-:^FDA package insert:Nar
Clinical studies section:-:-:^FDA package insert:Narrative
Clinical Studies-Subcommittee D
Clinical Study
Clinical Study Activation Date
Clinical Study Activity Description
Clinical Study Activity Relationship
Clinical Study Activity Relationship Comment
Clinical Study Activity Relationship Type
Clinical Study Actual Accrual
Clinical Study Actual Accrual Number
Clinical Study by Design
Clinical Study by Intent
Clinical Study by Organizational Parameters
Clinical Study by Phase
Clinical Study by Product, Procedure, or Method Tested
Clinical Study by Targeted Disease or Condition
Clinical Study Case
Clinical Study Document Relationship Type
Clinical Study Element
Clinical Study Intent
Clinical Study Investigator Registration Status
Clinical Study Investigator Status
Clinical Study Investigator Status in Study
Clinical Study Lead Organization
Clinical Study Participant
Clinical Study Participating Organization
Clinical Study Population Subgroup
Clinical Study Protocol
Clinical Study Protocol Status
Clinical study registration message
Clinical Study Reports And Related Information
Clinical Study Site
Clinical Study Site Accrual Status
Clinical Study Site Active
Clinical Study Site by Role in Study
Clinical Study Site Pending IRB Approval
Clinical Study Site Pending IRB Approval Status
Clinical Study Site Role
Clinical Study Site Status
Clinical Study Site Targeted Accrual
Clinical Study Sponsor
Clinical Study Status
Clinical Study Subject Unique Identifier
Clinical Study Target Accrual
Clinical Study Targeted Accrual
Clinical study with phases and scheduled master file
Clinical study without phases but with scheduled master file
Clinical Summary
Clinical Summary: References
Clinical Term, SNOMED
Clinical Terms Version 3 (CTV3) (Read Codes)
Clinical Terms Version 3 (CTV3) (Read Codes), 1999
Clinical Terms, SNOMED
Clinical test of hearing
Clinical Test Result
Clinical Testing
clinical thermometer
clinical thermometers
Clinical TNM Finding
clinical traineeship
Clinical Treatment
Clinical trend
Clinical Trend | Wound
Clinical trend of Wound Observed
Clinical trend Wnd Observ
Clinical trend:Find:Pt:Wound:Nom:Observed
Clinical trend:Finding:Point in time:Wound:Nominal:Observed
Clinical triad - dysmorphic features, cardiac arrhythmia, and potassium-sensitive periodic paralysis
Clinical Trial
Clinical Trial [Publication Type]
Clinical Trial Agreement
Clinical Trial as Topic
Clinical Trial Eligibility Criteria
Clinical Trial Epoch
Clinical Trial Groups
Clinical Trial Overview
Clinical Trial Overviews
Clinical Trial Participant
clinical trial participant (history)
Clinical trial participant (person)
Clinical Trial Period
clinical trial phase I
clinical trial phase II
clinical trial phase II/III/IV
clinical trial phase III
clinical trial phase IV
Clinical Trial Protocol
Clinical trial protocol Assessment of safety section
Clinical trial protocol Assessment section
Clinical trial protocol Background information section
Clinical trial protocol Clinical trial protocol
Clinical trial protocol Data handling and record keeping section
Clinical trial protocol Direct access to source data+documents section
Clinical trial protocol document
Clinical trial protocol Efficacy assessment section
Clinical trial protocol Ethics section
Clinical trial protocol Financing and insurance section
Clinical trial protocol General information section
Clinical trial protocol Publication policy section
Clinical trial protocol Quality control and quality assurance section
Clinical trial protocol Statistics section
Clinical trial protocol Subject participation + epochs section
Clinical trial protocol Subject selection and withdrawal section
Clinical trial protocol Supplements section
Clinical trial protocol Treatment of subjects + epochs section
Clinical trial protocol Trial design section
Clinical trial protocol Trial name
Clinical trial protocol Trial objectives & purpose section
Clinical trial protocol.total
Clinical trial protocol.total | Clinical trial protocol
Clinical trial protocol.total | Clinical trial protocol | Bld-Ser-Plas
Clinical trial protocol.total:-:-:^Clinical trial protocol:Nar
Clinical trial protocol.total:-:-:^Clinical trial protocol:Narrative
Clinical Trial Site
Clinical Trial Site Status
Clinical Trial Subject
Clinical Trial Targeted Accrual
clinical trial timepoint event
Clinical Trial Type
Clinical Trial, Adjunct
Clinical Trial, Other
Clinical Trial, Phase 1
Clinical Trial, Phase 2
Clinical Trial, Phase 3
Clinical Trial, Phase 4
Clinical Trial, Phase I
Clinical Trial, Phase II
Clinical Trial, Phase III
Clinical Trial, Phase III (publication)
Clinical Trial, Phase IV
Clinical Trial, Phase IV (publication)
Clinical Trials
Clinical Trials as Topic
Clinical Trials Cooperative Group
Clinical Trials Cooperative Groups
Clinical Trials Cooperative Groups Human Tissue Resources
Clinical Trials Data Monitoring Committees
Clinical Trials Database
Clinical Trials Design
clinical trials in animals
Clinical Trials Informatics Support System
Clinical Trials Informatics System
Clinical Trials Information for Patients
Clinical Trials Information for Physicians
Clinical Trials Information Management System
Clinical Trials Program Review Group
Clinical Trials Protocol and Data Management Shared Resource
Clinical Trials Scientific Review and Monitoring System
Clinical Trials Support Unit
Clinical Trials, Adjunct
Clinical Trials, Controlled as Topic
Clinical Trials, Diagnosis
Clinical Trials, Monitoring
Clinical Trials, Other
Clinical Trials, Phase 1
Clinical Trials, Phase 3 as Topic
Clinical Trials, Phase 4 as Topic
Clinical Trials, Phase I
Clinical Trials, Phase I as Topic
Clinical Trials, Phase II
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III
Clinical Trials, Phase III as Topic
Clinical Trials, Phase IV
Clinical Trials, Phase IV as Topic
Clinical Trials, Prevention
Clinical Trials, Randomized
Clinical Trials, Therapy
Clinical Trials, Unspecified
Clinical Trials: Cancer Control
Clinical Trials: Cancer Treatment
Clinical Unit
CLINICAL UNITS
Clinical Use Template
Clinical variability
Clinical variation
Clinical vestibular function tests
Clinical Virology
Clinical, Surgery, Laser
Clinical, Transplantation, Immune System
Clinical, Transplantation, Organ
Clinical.estimated
Clinical.estimated from prior assessment
Clinical.estimated from prior gest age assessment
Clinical/Radiologic
ClinicalActionDetectedIssueCode
ClinicalDrug
clinically
Clinically classified into classic, atypical, and intermediate phenotypes
clinically dead
Clinically Isolated CNS Demyelinating Syndrome
Clinically Isolated Syndrome, CNS Demyelinating
Clinically mimics congenital TORCH infections
clinically proven
Clinically resembles essential tremor, but not responsive to beta-adrenergic blockers
Clinically resembles spinal muscular atrophy-1 (SMA1, {253300})
Clinically similar to torsion dystonia-1 (DYT1, {128100})
Clinically Unimportant Route of Excretion
Clinically Unimportant Route of Excretion [PK]
ClinicalOrganizationRoleType
clinician
Clinician diagnosis, comorbidity, and complication list is complete
Clinician diagnosis, comorbidity, and complication list is complete | patient
Clinician diagnosis, comorbidity, and complication list is complete | patient | Bld-Ser-Plas
Clinician diagnosis, comorbidity, and complication list is complete:Find:Pt:^Patient:Ord:CARE
Clinician diagnosis, comorbidity, and complication list is complete:Finding:Point in time:^Patient:Ordinal:CARE
Clinician did not doc
CLINICIAN DID NOT DOCUMENT A PROPHYLACTIC ANTIBIOTIC WAS ADMINISTERED WITHIN ONE HOUR (IF VANCOMYCIN, TWO HOURS) PRIOR TO SURGICAL INCISION (OR START OF PROCEDURE WHEN NO INCISION IS REQUIRED)
CLINICIAN DID NOT DOCUMENT AN ORDER WAS GIVEN FOR APPROPRIATE VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS TO BE GIVEN WITHIN 24 HRS PRIOR TO INCISION TIME OR 24 HOURS AFTER SURGERY END TIME
CLINICIAN DID NOT DOCUMENT AN ORDER WAS GIVEN TO DISCONTINUE PROPHYLACTIC ANTIBIOTICS WITHIN 24 HOURS OF SURGICAL END TIME
CLINICIAN DID NOT DOCUMENT AN ORDER WAS GIVEN TO DISCONTINUE PROPHYLACTIC ANTIBIOTICS WITHIN 48 HOURS OF SURGICAL END TIME
CLINICIAN DID NOT DOCUMENT THAT AN ORDER FOR PROPHYLACTIC ANTIBIOTIC TO BE GIVEN WITHIN ONE HOUR (IF VANCOMYCIN, TWO HOURS) PRIOR TO SURGICAL INCISION (OR START OF PROCEDURE WHEN NO INCISION IS REQUIRED) WAS GIVEN
CLINICIAN DID NOT PRESCRIBE ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITOR OR ANGIOTENSIN RECEPTOR BLOCKER (ARB) THERAPY, REASON NOT SPECIFIED
CLINICIAN DID NOT PROVIDE CARE TO PATIENT FOR THE REQUIRED TIME OF MAMMOGRAPHY MEASURE (I.E., MEASUREMENT YEAR OR PRIOR YEAR)
CLINICIAN DOCUMENTATION THAT BREAST CANCER PATIENT WAS NOT ELIGIBLE FOR TAMOXIFEN OR AROMATASE INHIBITOR THERAPY MEASURE
CLINICIAN DOCUMENTATION THAT COLON CANCER PATIENT IS NOT ELIGIBLE FOR CHEMOTHERAPY MEASURE
CLINICIAN DOCUMENTATION THAT PATIENT WAS AN ELIGIBLE CANDIDATE FOR BARIUM SWALLOW TEST
CLINICIAN DOCUMENTATION THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR ANTIOXIDANT VITAMIN OR MINERAL SUPPLEMENT DURING THE REPORTING YEAR
CLINICIAN DOCUMENTATION THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR CALCIUM AND VITAMIN D, AND EXERCISE DURING THE REPORTING YEAR
CLINICIAN DOCUMENTATION THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR DILATED MACULAR OR FUNDUS EXAM DURING THE REPORTING YEAR
CLINICIAN DOCUMENTATION THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR FALL RISK SCREENING
CLINICIAN DOCUMENTATION THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR MACULAR EXAMINATION DURING THE REPORTING YEAR
CLINICIAN DOCUMENTATION THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR PRE-SURGICAL AXIAL LENGTH, CORNEAL POWER MEASUREMENT AND METHOD OF INTRAOCULAR LENS POWER CALCULATION
CLINICIAN DOCUMENTATION THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR RADIATION THERAPY MEASURE
CLINICIAN DOCUMENTATION THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR THE FINDINGS OF THEIR MACULAR OR FUNDUS EXAM BEING COMMUNICATED TO THE PHYSICIAN MANAGING THEIR DIABETES CARE DURING THE REPORTING YEAR
CLINICIAN DOCUMENTED AN ORDER WAS GIVEN FOR APPROPRIATE VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS TO BE GIVEN WITHIN 24 HRS PRIOR TO INCISION TIME OR 24 HOURS AFTER SURGERY END TIME
CLINICIAN DOCUMENTED AN ORDER WAS GIVEN TO DISCONTINUE PROPHYLACTIC ANTIBIOTICS WITHIN 24 HOURS OF SURGICAL END TIME
CLINICIAN DOCUMENTED AN ORDER WAS GIVEN TO DISCONTINUE PROPHYLACTIC ANTIBIOTICS WITHIN 48 HOURS OF SURGICAL END TIME
CLINICIAN DOCUMENTED PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR DISCONTINUATION OF PROPHYLACTIC ANTIBIOTIC DISCONTINUATION WITHIN 48 HOURS OF SURGICAL END TIME
CLINICIAN DOCUMENTED PATIENT WITH LEFT VENTRICULAR EJECTION FRACTION (LVEF) <40% OR DOCUMENTATION AS MODERATELY OR SEVERELY DEPRESSED LEFT VENTRICULAR SYSTOLIC FUNCTION WAS NOT ELIGIBLE CANDIDATE FOR BETA-BLOCKER THERAPY
CLINICIAN DOCUMENTED PRESENCE OR ABSENCE ALARM SYMPTOMS
CLINICIAN DOCUMENTED RECONCILIATION OF DISCHARGE MEDICATIONS WITH CURRENT MEDICATION LIST IN MEDICAL RECORD
CLINICIAN DOCUMENTED THAT (FEMALE) PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR OSTEOPOROSIS ASSESSMENT MEASURE
CLINICIAN DOCUMENTED THAT ACUTE MYOCARDIAL INFARCTION PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR BETA-BLOCKER AT ARRIVAL MEASURE
CLINICIAN DOCUMENTED THAT ACUTE MYOCARDIAL INFARCTION PATIENT WAS NOT AN ELIGIBLE CANDIDATE TO RECEIVE ASPIRIN AT ARRIVAL MEASURE
CLINICIAN DOCUMENTED THAT COMMUNICATION WAS SENT TO THE PHYSICIAN MANAGING ONGOING CARE OF PATIENT THAT A FRACTURE OCCURRED AND THAT THE PATIENT WAS OR SHOULD BE TESTED OR TREATED FOR OSTEOPOROSIS
CLINICIAN DOCUMENTED THAT CORONARY ARTERY DISEASE PATIENT WAS NOT ELIGIBLE CANDIDATE FOR ANTIPLATELET THERAPY MEASURE
CLINICIAN DOCUMENTED THAT CORONARY ARTERY DISEASE PATIENT WAS NOT ELIGIBLE CANDIDATE FOR LOW-DENSITY LIPOPROTEIN MEASURE
CLINICIAN DOCUMENTED THAT DIABETIC PATIENT WAS NOT ELIGIBLE CANDIDATE FOR HEMOGLOBIN A1C MEASURE
CLINICIAN DOCUMENTED THAT DIABETIC PATIENT WAS NOT ELIGIBLE CANDIDATE FOR LOW-DENSITY LIPOPROTEIN MEASURE
CLINICIAN DOCUMENTED THAT END STAGE RENAL DISEASE PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR HEMATOCRIT (HEMOGLOBIN) MEASURE
CLINICIAN DOCUMENTED THAT END STAGE RENAL DISEASE PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR URR OR KT/V MEASURE
CLINICIAN DOCUMENTED THAT FEMALE PATIENT 65 YEARS OF AGE OR OLDER WHO SUFFERED A NONTRAUMATIC FRACTURE WITHIN THE LAST 6 MONTHS WAS NOT AN ELIGIBLE CANDIDATE FOR MEASURE TO TEST BONE MINERAL DENSITY OR DRUG TO TREAT OR PREVENT OSTEOPOROSIS
CLINICIAN DOCUMENTED THAT FEMALE PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR MAMMOGRAPHY MEASURE
CLINICIAN DOCUMENTED THAT HEART FAILURE PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR EITHER ANGIOTENSIN-CONVERTING ENZYME INHIBITOR OR ANGIOTENSIN-RECEPTOR BLOCKER (ACE-I OR ARB) THERAPY MEASURE
CLINICIAN DOCUMENTED THAT HEART FAILURE PATIENT WAS NOT ELIGIBLE CANDIDATE FOR BETA-BLOCKER THERAPY MEASURE
CLINICIAN DOCUMENTED THAT NEWLY DIAGNOSED OSTEOPOROSIS PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR ANTIRESORPTIVE THERAPY AND/OR PTH TREATMENT MEASURE WITHIN 3 MONTHS OF DIAGNOSIS
CLINICIAN DOCUMENTED THAT OSTEOPOROSIS PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR CALCIUM AND VITAMIN D SUPPLEMENT MEASURE
CLINICIAN DOCUMENTED THAT PATIENT DID NOT RECEIVE CONVENTIONAL CEA
CLINICIAN DOCUMENTED THAT PATIENT IS NOT AN ELIGIBLE CANDIDATE FOR COUNSELING REGARDING CONTRACEPTION PRIOR TO ANTIVIRAL TREATMENT; PATIENT NOT RECEIVING ANTIVIRAL TREATMENT FOR HEPATITIS C
CLINICIAN DOCUMENTED THAT PATIENT IS NOT AN ELIGIBLE CANDIDATE FOR GENOTYPE TESTING; PATIENT NOT RECEIVING ANTIVIRAL TREATMENT FOR HEPATITIS C
CLINICIAN DOCUMENTED THAT PATIENT IS NOT AN ELIGIBLE CANDIDATE FOR QUANTITATIVE RNA TESTING AT WEEK 12; PATIENT NOT RECEIVING ANTIVIRAL TREATMENT FOR HEPATITIS C
CLINICIAN DOCUMENTED THAT PATIENT IS NOT AN ELIGIBLE CANDIDATE FOR SUICIDE RISK ASSESSMENT; MAJOR DEPRESSIVE DISORDER, IN REMISSION
CLINICIAN DOCUMENTED THAT PATIENT IS RECEIVING ANTIVIRAL TREATMENT FOR HEPATITIS C
CLINICIAN DOCUMENTED THAT PATIENT RECEVIED VASCULAR ACCESS OTHER THAN AUTOGENOUS AV FISTULA, REASON NOT SPECIFIED
CLINICIAN DOCUMENTED THAT PATIENT WAS INELIGIBLE FOR PROPHYLACTIC ANTIBIOTIC SELECTION MEASURE
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR A SPECIFIC TARGET INTRAOCULAR PRESSURE RANGE GOAL
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR ABI MEASUREMENT MEASURE
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR AN ASSESSMENT OF THE PRESENCE OR ABSENCE OF URINARY INCONTINENCE
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITOR OR ANGIOTENSIN RECEPTOR BLOCKER (ARB) THERAPY
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR ANTIBIOTIC PROPHYLAXIS ONE HOUR PRIOR TO INCISION TIME (TWO HOURS FOR VANCOMYCIN) MEASURE
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR ANTICOAGULANT THERAPY AT DISCHARGE
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR ANTIDEPRESSANT MEDICATION DURING THE ENTIRE 12 WEEK ACUTE TREATMENT PHASE MEASURE
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR ANTIDEPRESSANT MEDICATION FOR CONTINUOUS TREATMENT PHASE
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR ANTIPLATELET THERAPY
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR ANTIPLATELET THERAPY AT DISCHARGE, INCLUDING IDENTIFICATION FROM MEDICAL RECORD THAT PATIENT IS ON ANTICOAGULATION THERAPY
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR APPROPRIATE EMPIRIC ANTIBIOTIC
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR ASSESSMENT OF VISUAL FUNCTIONAL STATUS
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR AUTOGENOUS AV FISTULA
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR CENTRAL DEXA MEASUREMENT OR PHARMACOLOGIC THERAPY
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR CENTRAL DEXA MEASUREMENT OR PRESCRIBING PHARMACOLOGIC
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR CORONARY ARTERY BYPASS GRAFT WITH USE OF INTERNAL MAMMARY ARTERY MEASURE
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR DVT PROPHYLAXIS BY THE END OF HOSPITAL DAY 2, INCLUDING PHYSICIAN DOCUMENTATION THAT PATIENT IS AMBULATORY
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR DYSPHAGIA SCREENING PRIOR TO TAKING ANY FOODS, FLUIDS OR MEDICATION BY MOUTH
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR ECG
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR ESOPHAGEAL BIOPSY
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR FOOTWEAR EVALUATION MEASURE
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR HEARING ASSESSMENT MEASURE
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR INFLUENZA VACCINATION MEASURE
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR LOWER EXTREMITY NEUROLOGICAL EXAM MEASURE
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR OPTIC NERVE HEAD EVALUATION DURING THE REPORTING YEAR
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR OXYGEN SATURATION ASSESSMENT
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR PHARMACOLOGIC THERAPY
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR PNEUMOCOCCAL VACCINATION MEASURE
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR PROPHYLACTIC ANTIBIOTIC
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR PROPHYLACTIC ANTIBIOTIC DISCONTINUATION WITHIN 24 HOURS OF SURGICAL END TIME
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR SCREENING OR THERAPY FOR OSTEOPOROSIS FOR WOMEN MEASURE
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR SURROGATE DECISION MAKER OR ADVANCE CARE PLAN
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR THE FALLS ASSESSMENT MEASURE WITHIN THE LAST 12 MONTHS
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR THROMBOEMBOLISM PROPHYLAXIS MEASURE
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR UPPER ENDOSCOPY
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR URINARY INCONTINENCE ASSESSMENT MEASURE
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS TO BE GIVEN WITHIN 24 HOURS PRIOR TO INCISION TIME OR 24 HOURS AFTER SURGERY END TIME
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT AN ELIGIBLE CANDIDATE TO RECEIVE ASPIRIN
CLINICIAN DOCUMENTED THAT PATIENT WAS NOT ELIGIBLE FOR CLINICAL STAGE PRIOR TO SURGERY FOR LUNG CANCER AND ESOPHAGEAL CANCER RESECTION MEASURE
CLINICIAN DOCUMENTED THAT PATIENT WHOSE FINAL REPORT OF THE CAROTID IMAGING STUDY PERFORMED (NECK MRA, NECK CTA, NECK DUPLEX ULTRASOUND, CAROTID ANGIOGRAM), WITH CHARACTERIZATION OF AN INTERNAL CAROTID STENOSIS IN THE 30-99% RANGE, WAS NOT AN ELIGIBLE CAN
CLINICIAN DOCUMENTED THAT PATIENT WITH A LEFT VENTRICULAR EJECTION FRACTION (LVEF) <40% OR DOCUMENTATION OF MODERATELY OR SEVERELY DEPRESSED LEFT VENTRICULAR SYSTOLIC FUNCTION WAS NOT AN ELIGIBLE CANDIDATE FOR ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITOR
CLINICIAN DOCUMENTED THAT PATIENT WITH HEART FAILURE AND ATRIAL FIBRILLATION WAS NOT AN ELIGIBLE CANDIDATE FOR WARFARIN THERAPY MEASURE
CLINICIAN DOCUMENTED THAT PATIENT WITH ISOLATED CORONARY ARTERY BYPASS GRAFT WAS NOT AN ELIGIBLE CANDIDATE FOR ANTIPLATELET THERAPY AT DISCHARGE MEASURE
CLINICIAN DOCUMENTED THAT PATIENT WITH ISOLATED CORONARY ARTERY BYPASS GRAFT WAS NOT AN ELIGIBLE CANDIDATE FOR PRE-OPERATIVE BETA-BLOCKADE MEASURE
CLINICIAN DOCUMENTED THAT PNEUMONIA PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR ANTIBIOTIC WITHIN 4 HOURS OF PRESENTATION MEASURE
CLINICIAN DOCUMENTED THAT PRIOR MYOCARDIAL INFARCTION - CORONARY ARTERY DISEASE PATIENT WAS NOT ELIGIBLE CANDIDATE FOR BETA-BLOCKER THERAPY MEASURE
CLINICIAN DOCUMENTED THAT PROPHYLACTIC ANTIBIOTIC WAS GIVEN
CLINICIAN DOCUMENTED THAT PROPHYLACTIC ANTIBIOTICS WERE DISCONTINUED WITHIN 24 HOURS OF SURGICAL END TIME
CLINICIAN DOCUMENTED THAT PROPHYLACTIC ANTIBIOTICS WERE DISCONTINUED WITHIN 48 HOURS OF SURGICAL END TIME
CLINICIAN DOCUMENTED THAT PROSTATE CANCER PATIENT IS NOT AN ELIGIBLE CANDIDATE FOR ADJUVANT HORMONAL THERAPY; LOW OR INTERMEDIATE RISK OF RECURRENCE OR RISK OF RECURRENCE NOT DETERMINED
CLINICIAN DOCUMENTED THAT SYMPTOMATIC OSTEOARTHRITIS PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR ANNUAL ASSESSMENT OF FUNCTION AND PAIN MEASURE
CLINICIAN DOCUMENTED THAT THE DIABETIC PATIENT WAS NOT ELIGIBLE CANDIDATE FOR BLOOD PRESSURE MEASURE
CLINICIAN DOCUMENTED TO HAVE GIVEN CEFAZOLIN OR CEFUROXIME FOR ANTIMICROBIAL PROPHYLAXIS
CLINICIAN DOCUMENTED TO HAVE GIVEN ORDER FOR PROPHYLACTIC ANTIBIOTIC TO BE GIVEN WITHIN ONE HOUR (IF VANCOMYCIN, TWO HOURS) PRIOR TO SURGICAL INCISION (OR START OF PROCEDURE WHEN NO INCISION IS REQUIRED)
CLINICIAN DOCUMENTED TO HAVE GIVEN THE PROPHYLACTIC ANTIBIOTIC WITHIN ONE HOUR (IF VANCOMYCIN, TWO HOURS) PRIOR TO THE SURGICAL INCISION (OR START OF PROCEDURE WHEN NO INCISION IS REQUIRED)
CLINICIAN DOCUMENTED TO HAVE GIVEN VTE PROPHYLAXIS WITHIN 24 HRS PRIOR TO INCISION TIME OR 24 HOURS AFTER SURGERY END TIME
CLINICIAN HAS NOT DOCUMENTED PRESENCE OR ABSENCE OF ALARM SYMPTOMS
CLINICIAN HAS NOT DOCUMENTED RECONCILIATION OF DISCHARGE MEDICATIONS WITH CURRENT MEDICATION LIST IN MEDICAL RECORD
CLINICIAN HAS NOT DOCUMENTED THAT COMMUNICATION WAS SENT TO THE PHYSICIAN MANAGING ONGOING CARE OF PATIENT THAT A FRACTURE OCCURRED AND THAT THE PATIENT WAS OR SHOULD BE TESTED OR TREATED FOR OSTEOPOROSIS
CLINICIAN HAS NOT PROVIDED CARE FOR THE AGE-RELATED MACULAR DEGENERATION PATIENT FOR THE REQUIRED TIME FOR ANTIOXIDANT SUPPLEMENT PRESCRIPTION/RECOMMENDED MEASURE
CLINICIAN HAS NOT PROVIDED CARE FOR THE AGE-RELATED MACULAR DEGENERATION PATIENT FOR THE REQUIRED TIME FOR MACULAR EXAMINATION MEASUREMENT
CLINICIAN HAS NOT PROVIDED CARE FOR THE CARDIAC PATIENT FOR THE REQUIRED TIME FOR LOW-DENSITY LIPOPROTEIN MEASURE (6 MONTHS)
CLINICIAN HAS NOT PROVIDED CARE FOR THE CATARACT PATIENT FOR THE REQUIRED TIME FOR ASSESSMENT OF VISUAL FUNCTIONAL STATUS MEASUREMENT
CLINICIAN HAS NOT PROVIDED CARE FOR THE CATARACT PATIENT FOR THE REQUIRED TIME FOR FUNDUS EVALUATION MEASUREMENT
CLINICIAN HAS NOT PROVIDED CARE FOR THE CATARACT PATIENT FOR THE REQUIRED TIME FOR PRE-SURGICAL MEASUREMENT AND INTRAOCULAR LENS POWER CALCULATION MEASURE
CLINICIAN HAS NOT PROVIDED CARE FOR THE DIABETIC PATIENT FOR THE REQUIRED TIME FOR BLOOD PRESSURE MEASURE (WITHIN THE LAST 6 MONTHS)
CLINICIAN HAS NOT PROVIDED CARE FOR THE DIABETIC PATIENT FOR THE REQUIRED TIME FOR HEMOGLOBIN A1C MEASURE (6 MONTHS)
CLINICIAN HAS NOT PROVIDED CARE FOR THE DIABETIC PATIENT FOR THE REQUIRED TIME FOR LOW-DENSITY LIPOPROTEIN MEASURE (12 MONTHS)
CLINICIAN HAS NOT PROVIDED CARE FOR THE DIABETIC RETINOPATHY PATIENT FOR THE REQUIRED TIME FOR MACULAR EDEMA AND RETINOPATHY MEASUREMENT
CLINICIAN HAS NOT PROVIDED CARE FOR THE DIABETIC RETINOPATHY PATIENT FOR THE REQUIRED TIME FOR PHYSICIAN COMMUNICATION MEASUREMENT
CLINICIAN HAS NOT PROVIDED CARE FOR THE PATIENT FOR THE REQUIRED TIME FOR CENTRAL DEXA MEASUREMENT OR PHARMACOLOGICAL THERAPY MEASURE
CLINICIAN HAS NOT PROVIDED CARE FOR THE PATIENT FOR THE REQUIRED TIME FOR THE CALCIUM, VITAMIN D, AND EXERCISE MEASURE
CLINICIAN HAS NOT PROVIDED CARE FOR THE PATIENT FOR THE REQUIRED TIME FOR THE PHARMACOLOGIC THERAPY MEASURE
CLINICIAN HAS NOT PROVIDED CARE FOR THE PATIENT FOR THE REQUIRED TIME TO DEVELOP PLAN OF CARE FOR URINARY INCONTINENCE
CLINICIAN HAS NOT PROVIDED CARE FOR THE PATIENT FOR THE REQUIRED TIME TO SCREEN FOR FALL RISK
CLINICIAN HAS NOT PROVIDED CARE FOR THE PRIMARY OPEN-ANGLE GLAUCOMA PATIENT FOR THE REQUIRED TIME FOR OPTIC NERVE HEAD EVALUATION MEASURE
CLINICIAN HAS NOT PROVIDED CARE FOR THE PRIMARY OPEN-ANGLE GLAUCOMA PATIENT FOR THE REQUIRED TIME FOR TREATMENT RANGE GOAL DOCUMENTATION MEASUREMENT
CLINICIAN INTENDS TO REPORT THE END STAGE RENAL DISEASE (ESRD) MEASURE GROUP
CLINICIAN PRESCRIBED ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITOR OR ANGIOTENSIN RECEPTOR BLOCKER (ARB) THERAPY
CLINICIAN STAGE PRIOR TO SURGERY FOR LUNG CANCER AND ESOPHAGEAL CANCER RESECTION WAS NOT RECORDED, REASON NOT SPECIFIED
Clinician, Nurse
clinicians
Clinicians, Nurse
Clinicide
Clinicide 5 MG/ML Topical Lotion
Cliniclean
Clinico-Pathologic Conference
Clinico-Pathological Conference
Clinics
Clinics and Hospitals
CLINICS DENT
Clinics or Hospitals
CLINICS VET
Clinics, Abortion
Clinics, Child Guidance
Clinics, Dental
Clinics, Free Standing
Clinics, Free-Standing
Clinics, Hospital Outpatient
Clinics, Multidisciplinary Pain
Clinics, Nurse-Led
Clinics, Outpatient
Clinics, Pain
Clinics, Urgent Care
Clinics, Veterinary
Clinidae
Clinidine
Clinidine 100 MG/ML Topical Solution
Clinidine, 10% topical solution
Clinidium
Clinidium baldufi
Clinidium baldufi Bell, 1970
Clinidium calcaratum
Clinimix
Clinimix 2.75/5
CLINIMIX 2.75/5 INJ
Clinimix 2.75/5 Injectable Solution
Clinimix 2.75/5 Sulfite-Free 2.75% in Dextrose 5% Solution for Injection
Clinimix 4.25/10
Clinimix 4.25/10 Injectable Solution
Clinimix 4.25/10 Sulfite-Free 4.25% in Dextrose 10% Solution for Injection
Clinimix 4.25/20
CLINIMIX 4.25/20 INJ
Clinimix 4.25/20 Injectable Solution
Clinimix 4.25/20 Sulfite-Free 4.25% in Dextrose 20% Solution for Injection
Clinimix 4.25/25
Clinimix 4.25/25 Injectable Solution
Clinimix 4.25/25 Sulfite-Free 4.25% in Dextrose 25% Solution for Injection
Clinimix 4.25/5
CLINIMIX 4.25/5 INJ
Clinimix 4.25/5 Injectable Solution
Clinimix 4.25/5 Sulfite-Free 4.25% in Dextrose 5% Solution for Injection
Clinimix 5/15
CLINIMIX 5/15 INJ
388 389 390 391 392